Although induction of cardiac hypertrophy is a multifaceted process, inhibition of Shp2 activity through AKAP-Lbc-anchored PKA is a previously unrecognized mechanism that may promote cardiac hypertrophy in response to chronic β-adrenergic stimulation. Here, AKAP13 is linked to cardiac hypertrophy.